Inhibition of Thrombin Receptor Signaling on α-Smooth Muscle Actin + CD34 + Progenitors Leads to Repair After Murine Immune Vascular Injury
Author(s) -
Daxin Chen,
Seema Shrivastava,
Liang Ma,
El Li Tham,
Joel Abrahams,
J. David Coe,
Diane Scott,
Robert I. Lechler,
John H. McVey,
Anthony Dorling
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.239046
Subject(s) - cd34 , neointima , tissue factor pathway inhibitor , thrombin , microbiology and biotechnology , biology , progenitor cell , tissue factor , immunology , chemistry , cancer research , stem cell , medicine , platelet , restenosis , stent , coagulation
The goal of this study was to use mice expressing human tissue factor pathway inhibitor (TFPI) on α-smooth muscle actin (α-SMA)(+) cells as recipients of allogeneic aortas to gain insights into the cellular mechanisms of intimal hyperplasia (IH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom